FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns

The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus season in the fall. 

from Health and Science https://ift.tt/uEGpiB5
https://ift.tt/KeSAsMN
https://ift.tt/NDQ29ry